as 07-11-2025 2:21pm EST
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
Founded: | 1985 | Country: | United States |
Employees: | N/A | City: | MARLBOROUGH |
Market Cap: | 14.5B | IPO Year: | 1990 |
Target Price: | $77.73 | AVG Volume (30 days): | 2.4M |
Analyst Decision: | Buy | Number of Analysts: | 13 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | 2.39 | EPS Growth: | 25.36 |
52 Week Low/High: | $51.90 - $84.67 | Next Earning Date: | 07-30-2025 |
Revenue: | $4,026,500,000 | Revenue Growth: | 1.66% |
Revenue Growth (this year): | 2.99% | Revenue Growth (next year): | 4.91% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Madaus Martin D | HOLX | Director | May 7 '25 | Buy | $55.24 | 5,445 | $300,760.02 | 5,445 |
HOLX Breaking Stock News: Dive into HOLX Ticker-Specific Updates for Smart Investing
StockStory
16 days ago
Simply Wall St.
16 days ago
Zacks
17 days ago
Zacks
19 days ago
Zacks
19 days ago
Barchart
22 days ago
Zacks
24 days ago
Zacks
a month ago
The information presented on this page, "HOLX Hologic Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.